2016-03-07T00:00:00.000-05:00
AnalystRatings.NET reports,-0.306191
debilitating genetic diseases,-0.61151
clinical-stage biopharmaceutical company,0.292876
quarter worth,0.300976
strong buy rating,0.351046
price objective,0.425193
Asset Management Inc.,0.477702
DekaBank Deutsche Girozentrale,0.119025
insider Sunil Agarwal,-0.22946
stock,0.121989
consensus price target,0.438801
Monday,0.114075
Pharmaceutical Inc Daily,0.385693
Eagle Asset Management,0.477702
InvestorPlace Broker Center,0.555736
Rockefeller Financial Services,0.455317
biopharmaceutical company,0.356668
personal trading style,0.598412
average rating,-0.270142
Candriam Luxembourg S.C.A.,0.342273
research note,0.299703
Stifel Nicolaus,0.212036
average price,0.23298
shares,0.130889
company’s stock,0.240193
concise daily summary,0.502738
Jennison Associates,0.300975
stock broker,0.245696
rating,0.0866792
Financial Services Inc.,0.455317
new stake,0.300976
Ultragenyx Pharmaceutical,-0.0365013
quarter,0.168961
